To study the effect of Tab HFO-O2 in fatty individuals.

Not Applicable

Completed

• Registration Number: CTRI/2016/07/007067
• Lead Sponsor: Baidyanath Bhavan Pvt Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Overweight individuals (Body Mass Index between 25-30) with controlled co-morbid dyslipidemia and/or hypertension and/or type 1 or type 2 diabetes

2.Stable body weight (less than 5 kg self-reported change during the previous 3 months)

3.Age between 18 years and 60 years

4.Individuals found compliant based on the Million Behavioural Medicine Diagnostic (MBMD)

5.Willing to give Informed consent before any trial-related activity takes place

Exclusion Criteria

1.Known case of endocrinological disorders such as hyper/hypo thyroidism, Poly Cystic Ovarian Syndrome (PCOS)

2.History of use one month before screening /currently using Allopathic or Ayurvedic medicines that may cause significant weight gain

3.History of use one month before screening /currently using dietary supplements, over-the-counter medications or below mentioned Allopathic /Ayurvedic medicines for weight loss

4.Current participation (past one month) in an organized weight reduction program

â??

5.Participants with a history of major depressive or other severe psychiatric disorders or an eating disorder [judged by frequency and quantity of food]

6.Surgery scheduled for the trial duration period, except for minor surgical procedures, at the discretion of the investigator

7.Pregnant or lactating females

Study & Design

• Study Type: Interventional
• Study Design: Not specified